"Permissive AKI" with treatment of heart failure.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 31648696.
- Also identified by DOI 10.1016/j.kint.2019.07.003.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Renin-angiotensin-aldosterone system inhibitors have proven clinical benefit in management of patients with heart failure with reduced ejection fraction. However, there are no guidelines to manage decline in kidney function that occurs with initiation and titration of renin-angiotensin-aldosterone system agents during management of heart failure. We discuss the complex interplay of kidney function and heart failure in the presence of renin-angiotensin-aldosterone system agents and suggest a clinical algorithm for management of acute decline in kidney function.
Medical subject headings
- Acute Kidney Injury
- Heart Failure